|
Per Wold-Olsen has been a director of our company since November 2006. He recently retired from Merck and Co., Inc. in October, 2006. From 1973 to 2006, Mr. Wold-Olsen has held various leadership positions with Merck and Co., Inc., most recently serving in the position of president, human health intercontinental and responsible for Europe, Eastern Europe, Middle East/Africa, India, Latin America and Canada regions from September 2005 until September 2006. From January 1997 to September 2005, he served as president, human health Europe, Middle East/Africa and worldwide human health marketing and was a member of the Merck management committee from September 1994 to September 2006. Mr. Wold-Olsen currently is a member of Royal Dutch Numico N.V.’s supervisory board, is a member of the BankInvest Biomedical Venture Advisory Board, is a member of H. Lundbeck A/S’s board of directors and a member of the supervisory board of World Growth, USA. | 